ReviewCureus2024

The Efficacy and Safety of Inclisiran for Low-Density Lipoprotein (LDL) in Patients With Atherosclerotic Cardiovascular Disease (ASCVD): A Systematic Review of Randomized Controlled Trials.

Hyder Mirghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.